Profiles

Peter Doherty Nature Medicine, June 2007
With opinions on nearly everything under the sun, Nobel Laureate Peter Doherty is an equal opportunity offender. But he has always saved his best ideas for science.

India’s watchdog: A breath of fresh air Nature, February 2007
How often does independent research change laws as well as minds? A lobby group in Delhi is forcing the Indian government into new regulations. Apoorva Mandavilli meets its leader.

Wafaa-el-Sadr Nature Medicine, March 2007
With a life dedicated to underserved populations from New York to the farthest corners of Africa, Wafaa El-Sadr has earned a reputation among her colleagues as the closest thing to a saint they’ll ever meet.

Stephen Lewis Nature Medicine, October 2006
In a roomful of stuffy diplomats, Stephen Lewis stands out for his powerful rhetoric and punchy humor. More than once, his habit for speaking uncomfortable truths has shamed governments into action.

Yoshihiro Kawaoka Nature Medicine, May 2006
Even in a constant state of jetlag, Yoshihiro Kawaoka is a fiercely productive flu researcher. Wonder what he could accomplish with a little bit of sleep?

Thomas Frieden Nature Medicine, April 2006
It’s not often that the health official of a city makes global headlines—even when the city in question is New York. With his daring policies on HIV, diabetes and smoking, Thomas Frieden is putting New York on the map.

Hui Zhen Sheng Nature Medicine, March 2006
As a stem cell researcher in China, Hui Zhen Sheng has had more trouble in the past few years than most researchers ever encounter. But you’ll never hear her complain about it.

Dominique Toran-Allerand Nature Medicine, October 2005
Don’t call her a women’s health researcher, but Dominique Toran-Allerand knows more about estrogen than almost anyone else. And she earned that knowledge by questioning dogma every step of the way.

Michael Malim Nature Medicine, June 2005
Long after others had given up, Michael Malim stayed in dogged pursuit of a protein that can stop HIV in its tracks. On the way to success, he also managed to make his colleagues laugh.

Woo-Suk Hwang Nature Medicine, May 2005
In the West, Woo-Suk Hwang is an enigma. In his home country, he is a scientist with perhaps too much power. In either place, he is a stem cell star.

David Ho Nature Medicine, November 2004
Credited with some of the biggest breakthroughs in tackling HIV/AIDS, David Ho has been a star from the beginning. But in a field fraught with controversy, fame may have come at a cost.

Malik Peiris Nature Medicine, September 2004
If battling a viral illness for a week can be tiring, being consumed by it for years can be downright exhausting. Still, Malik Peiris labors on in his quest to conquer the elusive infections.

Yusuke Nakamura Nature Medicine, June 2004
Yusuke Nakamura might not win any popularity contests in his homeland, but friends and rivals agree that his unique blend of scientific skill and financial savvy makes him the most influential force in Japanese research.

Jeff Friedman Nature Medicine, February 2004
When Jeff Friedman began his career as a doctor, there was slim chance he would wind up a world-renowned researcher at Rockefeller University. But his discovery of leptin turned this ‘accidental scientist’ into a heavyweight among obesity researchers.

Marc Tessier-Lavigne Nature Medicine, January 2004
How do you top solving a century-old riddle in developmental neurobiology? By moving to a company with no commercial interest in neuroscience. For someone as ambitious as Marc Tessier-Lavigne, leaving academia for the biotech giant Genentech could be the perfect choice.

Robert Webster Nature Medicine, December 2003
Like the mythological heroine Cassandra, Robert Webster seemed destined to remain a prophet who was never to be believed. His vision has since been validated but, fortunately for the world, his predictions of disaster—an influenza pandemic—have not yet reached the proportions of Greek tragedy.

Patrick Brown Nature Medicine, November 2003
Even when the chips are stacked against him, microarray pioneer Patrick Brown remains an incurable optimist. After defeating dogma in biochemistry and genetics, Brown is taking on the world of publishing—and he still hasn’t run out of breath.

Dennis Burton Nature Medicine, April 2003
In HIV vaccine research—where the stakes are high both scientifically and financially—it is rare to find a scientist as universally liked as Dennis Burton. Tempering deep ambition with a deeper sense of integrity, Burton walks the fine line between competition and collaboration.

Q and As:

Straight talk from James Love Nature Medicine, September 2007
In early August, a court in the southern Indian city of Chennai dismissed a lawsuit filed by pharmaceutical giant Novartis. James Love, director of the nonprofit organization Knowledge Ecology International, explains the local lawsuit’s global impact.

Straight talk from Jim Young Nature Medicine, May 2007
On 29 March, an advisory committee of the US Food and Drug Administration recommended approval of Provenge, a vaccine for prostate cancer made by Seattle-based Dendreon Corp. Provenge (sipuleucel-T) is a so-called dendritic cell vaccine, intended to stimulate the body’s own immune system to fight the cancer. The panel voted 13 to 4 in the vaccine’s favor. Jim Young, a dendritic cell expert at the Memorial Sloan-Kettering Cancer Center in New York, weighs in on the vaccine’s potential and its impact on the field at large.

One thought on “Profiles

  1. Two types of HIV have been characterized: HIV-1 and HIV-2. HIV-1 is the virus that was initially discovered and termed both LAV and HTLV-III. It is more virulent, more infective, and is the cause of the majority of HIV infections globally. The lower infectivity of HIV-2 compared to HIV-1 implies that fewer of those exposed to HIV-2 will be infected per exposure. ..-,;

    Kind thoughts
    http://healthmedicinebook.comug

Leave a Reply

Your email address will not be published. Required fields are marked *